Clinical Trials Directory

Trials / Completed

CompletedNCT01640197

Chronic Resveratrol Supplementation in Healthy Humans

The Effects of Chronic Trans- Resveratrol Supplementation on Aspects of Cognitive Performance, Mood, Sleep, Health and Cerebral Blood Flow in Healthy, Young Humans.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Northumbria University · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The effects of chronic resveratrol supplementation have yet to be investigated in healthy humans. It is hypothesised that the effects will be different to those seen in acute supplementation. This study will look specifically at cognitive performance, cerebral blood flow, subjective sleep, mood and health, blood pressure and plasma levels of resveratrol. It is hypothesized that these measures will be affected differently by acute and chronic supplementation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTResveratrolTransmax (Biotivia). 500mg (1 capsule) per day for 28 days.
OTHERPlaceboMethyl Cellulose. 1 capsule taken once daily for 28 days.

Timeline

Start date
2011-02-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2012-07-13
Last updated
2012-10-19
Results posted
2012-10-12

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01640197. Inclusion in this directory is not an endorsement.

Chronic Resveratrol Supplementation in Healthy Humans (NCT01640197) · Clinical Trials Directory